-
1دورية أكاديمية
المؤلفون: Gerstein, Hertzel C., Coleman, Ruth L., Scott, Charles A.B., Xu, Shishi, Tuomilehto, Jaakko, Rydén, Lars, Holman, Rury R., ACE Study Group
المصدر: Diabetes Care; Sep2020, Vol. 43 Issue 9, p2242-2247, 6p
مصطلحات موضوعية: CORONARY disease, BLOOD sugar, ACARBOSE, GLUCOSE tolerance tests, CHINESE people, HYPERGLYCEMIA, BLOOD sugar analysis, DIABETES prevention, GLUCOSE intolerance, DISEASE progression, RESEARCH, RESEARCH methodology, DIABETES, DISEASE incidence, MEDICAL cooperation, EVALUATION research, COMPARATIVE studies, GLYCOSIDASES, BLIND experiment, ANGIOTENSIN receptors, PREDIABETIC state, LONGITUDINAL method, CHEMICAL inhibitors, DISEASE complications
مصطلحات جغرافية: CHINA
-
2دورية أكاديمية
المؤلفون: Cefalu, William T., Kaul, Sanjay, Gerstein, Hertzel C., Holman, Rury R., Zinman, Bernard, Skyler, Jay S., Green, Jennifer B., Buse, John B., Inzucchi, Silvio E., Leiter, Lawrence A., Raz, Itamar, Rosenstock, Julio, Riddle, Matthew C.
المصدر: Diabetes Care; Jan2018, Vol. 41 Issue 1, p14-31, 18p
مصطلحات موضوعية: TYPE 2 diabetes, CARDIOVASCULAR diseases, HYPOGLYCEMIC agents, DIABETES, MORTALITY, CLINICAL trials, CARDIOVASCULAR disease prevention, INSULIN therapy, THERAPEUTIC use of protease inhibitors, TYPE 2 diabetes complications, BIOLOGICAL assay, CARDIOVASCULAR system, GLYCOSIDASES, CHEMICAL inhibitors
الشركة/الكيان: AMERICAN Diabetes Association
-
3دورية أكاديمية
المؤلفون: Wamil, Malgorzata1 (AUTHOR), McMurray, John J.V.2 (AUTHOR), Scott, Charles A.B.1 (AUTHOR), Coleman, Ruth L.1 (AUTHOR), Sun, Yihong3 (AUTHOR), Standl, Eberhard4 (AUTHOR), Rydén, Lars5 (AUTHOR), Holman, Rury R.1 (AUTHOR) rury.holman@dtu.ox.ac.uk
المصدر: Diabetes Research & Clinical Practice. Dec2020, Vol. 170, pN.PAG-N.PAG. 1p.
مصطلحات موضوعية: *CORONARY disease, *HEART failure patients, *CARDIAC patients, *HEART failure, *TYPE 2 diabetes, *ACARBOSE, *GLUCOSE intolerance, *MYOCARDIAL infarction, *DISEASE incidence, *TREATMENT effectiveness, *GLYCOSIDASES, *PROPORTIONAL hazards models, *CREATININE, *CHEMICAL inhibitors, MYOCARDIAL infarction-related mortality